A/ProfAlessandro Castorina
Associate Professor
Discipline of Medical Science
Orcid identifier0000-0001-7037-759X (opens in a new tab)
- Associate ProfessorDiscipline of Medical Science
- University of Technology Sydney, School of Life Sciences, Faculty of Science, 15, Broadway, Ultimo, Sydney, NSW, 2007, Australia
FUNDED RESEARCH
A/Prof Castorina research interests in the last fifteen years have been focused on investigating the broad function of two neuroprotective/immunomodulatory neuropeptides known as PACAP and VIP in cellular and experimental models of CNS diseases, with the aim to get a better understanding of the potential therapeutical implications of these endogenous protective molecules in the treatment of neurodegenerative / neuroinflammatory / neurological / neurotraumatic conditions.
A parallel line of research, in collaboration with UTS internal and external partners, has been to unveal the contribution of novel environmental risk factors in the genesis and progression of multiple sclerosis.
Using advanced molecular biology techniques, sophisticated transgenic mice and supported by brain tissue banks and a team of expert bioinformaticians, A/Prof. Castorina has now focused his research towards understanding the causes of impaired myelin regeneration and the identification of novel treatments to enhance neuroprotection and promote myelin self-reparative responses.
These research is essential and complementary to existing treatments, primarily aimed to suppress the dysfunctional immune system.
A parallel line of research, in collaboration with UTS internal and external partners, has been to unveal the contribution of novel environmental risk factors in the genesis and progression of multiple sclerosis.
Using advanced molecular biology techniques, sophisticated transgenic mice and supported by brain tissue banks and a team of expert bioinformaticians, A/Prof. Castorina has now focused his research towards understanding the causes of impaired myelin regeneration and the identification of novel treatments to enhance neuroprotection and promote myelin self-reparative responses.
These research is essential and complementary to existing treatments, primarily aimed to suppress the dysfunctional immune system.
FUNDED RESEARCH
- GRANTSydney Myelin Network: Forging the oligodendrocyte pathology research hub at UTSUniversity of Technology Sydney28 Apr 2025 - 31 Dec 2025People funded by this grant:
- Tse KH,
- Castorina A,
- Brew B
- PHILANTHROPIC FUNDINGTargeting the GABA system to promote CNS remyelinationThe Trustee for the Brain Australia Trust31 Mar 2023 - 30 Mar 2024People funded by this grant:
- Castorina A,
- Jansen M,
- Marzagalli R,
- Piper J
- GRANTAzetidine-2-carboxylic acid - a plant-derived non-protein amino acid as a novel environmental risk factor for MSMULTIPLE SCLEROSIS RESEARCH AUSTRALIA LIMITED1 Oct 2021 - 30 Sep 2022People funded by this grant:
- Castorina A,
- Piper J,
- Thomas Broome S,
- Rodgers K,
- Violi J
- GRANTNeuropeptide-based approach to improve myelin repair in Multiple SclerosisTHE TRUSTEE FOR THE REBECCA L COOPER MEDICAL RESEARCH FOUNDATION1 Apr 2020 - 31 Mar 2022People funded by this grant:
- Castorina A,
- Piper J,
- Al-Badri G,
- Thomas Broome S